FDA explains plans to bolster cell and gene therapy approvals through wider messaging

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)ComplianceHealth Authority meeting and communication strategyNorth AmericaQuality Assurance and ControlRegulatory Intelligence/Policy